Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Immune Mechanisms and Cytokine Profiles in Hemophilia a Patients Undergoing Low-Dose ITI and Emicizumab Prophylaxis: Implications for ITI Success and Failure

Jessica O. Frade-Guanaes, Carolina Costa-Lima, Vanessa B. Faiotto, Ana P. Francisco, Nívia M. Foschi, Andrea L. A. Sambo, Mariana M. T. Hosokawa, Valdirene Stahl, Luiz G. R. Lima, Bianca Stefanello, Lucas W. Weiss Santos, Samuel S. Medina, Marina P. Colella, Silmara A. De Lima Montalvão, Gabriela G. Yamaguti-Hayakawa, Margareth C. Ozelo

Blood (2024) 144 (Supplement 1): 720.

https://doi.org/10.1182/blood-2024-209350

Published: 2024

Journal Articles

Incidence of Inhibitors in Previously Untreated Patients with Severe Hemophilia a Treated with Plasma-Derived Vs. Recombinant Factor VIII Concentrates: A Systematic Review and Meta-Analyses

Alessandra N L Prezotti, Paula Ribeiro Villaça, Debora M C Rocha, Maria P S V Orletti, Christiane Lourenço, Gabriela G Yamaguti Hayakawa, Margareth C Ozelo

Blood (2022) 140 (Supplement 1): 57–58.

https://doi.org/10.1182/blood-2022-171028

Published: 2022

Journal Articles

Acquired Hemophilia a Relapse Is Related to Th2 Response, and Increased Expression of B-Cell Activating Factor (BAFF)

Jessica O Frade-Guanaes, Ana P Racanelli, Lucia H Siqueira, Carolina Costa-Lima, Samuel S Medina, Nivia M Foschi, Marina P Colella, Silmara A L Montalvão, Gabriela G Yamaguti-Hayakawa, Margareth C Ozelo

Blood (2021) 138 (Supplement 1): 497.

https://doi.org/10.1182/blood-2021-152589

Published: 2021

Journal Articles

Global Fibrinolysis Analysed By Clofal Method Is Not Associated with Post-Thrombotic Syndrome or Presence of Residual Vein Thrombosis in Patients with DVT in the Chronic Phase

Beatriz Moraes Martinelli, BSc, Stephany Cares Huber, PhD, Isabella Macedo Toni, MSc, Gabriela G Yamaguti-Hayakawa, MD, Gabriele Silva Souza Gois, Silmara Aparecida De Lima Montalvão, PhD, Joyce Maria Annichino- Bizzacchi, MD PhD

Blood (2019) 134 (Supplement_1): 2403.

https://doi.org/10.1182/blood-2019-131928

Published: 2019

Journal Articles

Association of Plasmic Score with Neurological Symptoms in Patients with Thrombotic Thrombocytopenic Purpura (TTP)

Jose Thiago de Souza Castro, Letícia Rittner, Simone Appenzeller, Gabriela G Yamaguti-Hayakawa, MD, Marina Colella, Erich V De Paula, MD PhD, Joyce Maria Annichino- Bizzacchi, MD PhD, Fabiano Reis, Fernanda Andrade Orsi, MD

Blood (2019) 134 (Supplement_1): 4894.

https://doi.org/10.1182/blood-2019-129144

Published: 2019

Journal Articles

A Retrospective Analysis of 122 Immune Thrombocytopenia Patients Treated with Dapsone: Efficacy, Safety and Factors Associated with Treatment Response

Marina Pereira Colella, MD, Elizio Chiacchio Ferraz Alves, MD, Gabriela de França Delmoro, Gabriela G Yamaguti-Hayakawa, MD, Fernanda Andrade Orsi, MD, Erich Vinicius De Paula, MD PhD, Joyce Maria Annichino- Bizzacchi, MD PhD

Blood (2018) 132 (Supplement 1): 737.

https://doi.org/10.1182/blood-2018-99-116467

Published: 2018

Journal Articles

Incidence of Inhibitors in a Previously Untreated Patients with Severe Hemophilia Α Cohort Treated with a Single Third-Generation Recombinant Factor VIII Concentrate

Alessandra N L Prezotti, MD MSc, Monica H Cerqueira, MD PhD, Marilia Renni, MD MSc, Clarissa Ferreira, MD, Ieda S. Pinto, MD, Maria do Rosário Roberti, MD PhD, Rosangela Ribeiro, MD, Paula Ribeiro Villaça, MD PhD, Maria P S V Orletti, Carolina Costa-Lima, MD MSc, Gabriela G Yamaguti-Hayakawa, MD, Samuel S Medina, MD MSc, Margareth C Ozelo, MD PhD

Blood (2018) 132 (Supplement 1): 1211.

https://doi.org/10.1182/blood-2018-99-119754

Published: 2018

Journal Articles

Clinical Course of Primary Immune Thrombocytopenia with Positive Antiphospholipid Antibodies

Ana Clara Cruz, Sabrina Saraiva, Marina Pereira Colella, MD, Gabriela G Yamaguti Hayakawa, MD, Erich Vinicius De Paula, MD PhD, Joyce Maria Annichino Bizzacchi, MD PhD, Fernanda Andrade Orsi, MD

Blood (2018) 132 (Supplement 1): 1159.

https://doi.org/10.1182/blood-2018-99-110170

Published: 2018

Journal Articles

Vinorelbine-Based Hematopoietic Stem-Cell Mobilization: A More Effective, Low-Cost Alternative to Conventional Chemotherapy

Bruno Kosa Lino Duarte, MD, Marcos Paulo Colella, MD MSc, Fernando Vieira Pericole Souza, MD PhD, Gabriela G Yamaguti-Hayakawa, MD, Jose Francisco Comenalli Marques, Jr., MD PhD, Afonso Celso Vigorito, MD PhD, Erich Vinicius De Paula, MD PhD, Margareth C Ozelo, MD PhD

Blood (2018) 132 (Supplement 1): 4762.

https://doi.org/10.1182/blood-2018-99-119884

Published: 2018

Journal Articles

A Simple Bundle to Control an Outbreak of Carbapenem-Resistant Enterobacteriacae in an Onco-Hematological Inpatient Unit: Report from a Single Center

Bruno K L Duarte, Gabriela G Yamaguti Hayakawa, MD, Francisco A Ferreira, MD, Katia B B Pagnano, MD PhD, Erich Vinicius De Paula, MD PhD, Margareth C Ozelo, MD PhD

Blood (2017) 130 (Supplement 1): 4651.

https://doi.org/10.1182/blood.V130.Suppl_1.4651.4651

Published: 2017

Journal Articles

Evaluation of Predictors of Outcome in Immune Tolerance Induction Treatment of Hemophilia Α Patients with High-Responding Inhibitors

Alessandra N L Prezotti, MD, Clarissa Ferreira, MD, Luciana Oliveira, MD PhD, Claudia Lorenzato, MD PhD, Maria P S V Orletti, Maria do Rosario Roberti, MD PhD, Rosangela Ribeiro, MD, Paula Ribeiro Villaca, MD PhD, Silmara Aparecida De Lima Montalvão, Samuel S Medina, MD, Gabriela G Yamaguti Hayakawa, MD, Margareth C Ozelo, MD PhD

Blood (2017) 130 (Supplement 1): 2357.

https://doi.org/10.1182/blood.V130.Suppl_1.2357.2357

Published: 2017

Journal Articles

Somatic Mutations Associated with Myeloid Transformation of RUNX1 -Mutated Familial Platelet Disorders with Propensity to Myeloid Malignancies Using Targeted Next-Generation Sequencing

Bruno K L Duarte, Samuel S Medina, MD, Gabriela G Yamaguti Hayakawa, MD, Fernando Ferreira Costa, MD PhD, Michael J. Rauh, MD PhD, Margareth C Ozelo, MD PhD

Blood (2017) 130 (Supplement 1): 2482.

https://doi.org/10.1182/blood.V130.Suppl_1.2482.2482

Published: 2017

Journal Articles

High Risk of Acute Myeloid Leukemia in Individuals with NAD(P)H:Quinone Oxidoreductase 1 ( NQO1 ) and Cytochrome P450 A1 ( CYP1A1 ) Gene Defects.

Gabriela G. Yamaguti, Gustavo J. Lourenco, M.Sc., Fernando F. Costa, Ph.D., Carmen S.P. Lima, Ph.D.

Blood (2007) 110 (11): 2843.

https://doi.org/10.1182/blood.V110.11.2843.2843

Published: 2007

NARROW

Immune Mechanisms and Cytokine Profiles in Hemophilia a Patients Undergoing Low-Dose ITI and Emicizumab Prophylaxis: Implications for ITI Success and Failure

Incidence of Inhibitors in Previously Untreated Patients with Severe Hemophilia a Treated with Plasma-Derived Vs. Recombinant Factor VIII Concentrates: A Systematic Review and Meta-Analyses

Acquired Hemophilia a Relapse Is Related to Th2 Response, and Increased Expression of B-Cell Activating Factor (BAFF)

Global Fibrinolysis Analysed By Clofal Method Is Not Associated with Post-Thrombotic Syndrome or Presence of Residual Vein Thrombosis in Patients with DVT in the Chronic Phase

Association of Plasmic Score with Neurological Symptoms in Patients with Thrombotic Thrombocytopenic Purpura (TTP)

A Retrospective Analysis of 122 Immune Thrombocytopenia Patients Treated with Dapsone: Efficacy, Safety and Factors Associated with Treatment Response

Incidence of Inhibitors in a Previously Untreated Patients with Severe Hemophilia Α Cohort Treated with a Single Third-Generation Recombinant Factor VIII Concentrate

Clinical Course of Primary Immune Thrombocytopenia with Positive Antiphospholipid Antibodies

Vinorelbine-Based Hematopoietic Stem-Cell Mobilization: A More Effective, Low-Cost Alternative to Conventional Chemotherapy

A Simple Bundle to Control an Outbreak of Carbapenem-Resistant Enterobacteriacae in an Onco-Hematological Inpatient Unit: Report from a Single Center

Evaluation of Predictors of Outcome in Immune Tolerance Induction Treatment of Hemophilia Α Patients with High-Responding Inhibitors

Somatic Mutations Associated with Myeloid Transformation of RUNX1 -Mutated Familial Platelet Disorders with Propensity to Myeloid Malignancies Using Targeted Next-Generation Sequencing

High Risk of Acute Myeloid Leukemia in Individuals with NAD(P)H:Quinone Oxidoreductase 1 ( NQO1 ) and Cytochrome P450 A1 ( CYP1A1 ) Gene Defects.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only